Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis: a proof-of-concept study.

Wittoek, Ruth; Carron, Philippe; Lambert, Bieke; Meersseman, Paulien; Verbruggen, Gust; Van den Bosch, Filip; Elewaut, Dirk

Wittoek, Ruth; Carron, Philippe; Lambert, Bieke; Meersseman, Paulien; Verbruggen, Gust; Van den Bosch, Filip; Elewaut, Dirk.

Afiliação

Wittoek R; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Carron P; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Lambert B; Department of Radiology and Nuclear Medicine, Ghent University, Ghent, Belgium.
Meersseman P; Department of Nuclear Medicine, AZ Maria Middelares, Ghent, Belgium.
Verbruggen G; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Van den Bosch F; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Elewaut D; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.

Ann Rheum Dis ; 77(2): 310-311, 2018 02.

Article em En | MEDLINE | ID: mdl-27932347

Assuntos

Certolizumab Pegol/administração & dosagem; Mãos/diagnóstico por imagem; Osteoartrite/diagnóstico por imagem; Radioimunodetecção/métodos; Fator de Necrose Tumoral alfa/metabolismo; Feminino; Mãos/patologia; Humanos; Masculino; Pessoa de Meia-Idade

Palavras-chave

DMARDs (biologic); Hand Osteoarthritis; TNF-alpha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite / Fator de Necrose Tumoral alfa / Radioimunodetecção / Certolizumab Pegol / Mãos Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google